<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet">
 <list-item>
  <p>Iron oxide nanoparticles: follow EMA and FDA guidance</p>
 </list-item>
 <list-item>
  <p>Liposomes: Follow FDA guidance</p>
 </list-item>
 <list-item>
  <p>Glatiramoids: in the absence of clear guidance, a case-based approach is recommended, where companies should ask for scientific advice from the EMA or FDA for the development of their products</p>
 </list-item>
 <list-item>
  <p>Polymeric micelles: follow EMA and FDA guidance.</p>
 </list-item>
</list>
